4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-010953
Chief Financial Officer sold 10,267 shares at $3.00 ($30,801)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. Chief Financial Officer | 2023-02-16 | Sale | −10,267 | $3.00 | $30,801 | 313,497 | D |
| Open-market sales · 10,267 sh · avg $3.00 · $30,801 | |||||||
Loading xslF345X03/doc4.xml…